Uncategorized

Big Pharma executives have not been shy about their desire for deals, but companies have been battling macro headwinds alongside Trump’s policies on drug pricing and tariff threats.

Amazon is reshuffling its various healthcare initiatives into six new divisions, each helmed by a longtime executive or One Medical leader.

The deal gets NextCure the rights to Simcere’s novel ADC for solid tumors outside of China.

Attorneys said many questions remain about the regulation of laboratory developed tests after the FDA lost its legal fight. A recent warning letter could be a clue to future enforcement.

Attorneys said many questions remain about LDT regulation after the FDA lost its legal fight. A recent warning letter could be a clue to future enforcement.

Coating for the guidewires could come off and get left in patients, which could result in extended or additional procedures. No serious injuries or deaths have been tied to the recall.

The guidance should help health systems safely manage and monitor AI tools in a financially sustainable manner, which can be “a real challenge” for providers, said CHAI CEO Dr. Brian Anderson.

At a satellite kickoff event to the annual BIO meeting, investment bankers and VCs gave reasons for optimism amid a ‘volatile’ period for the industry.

  El mercado tecnológico avanza rápidamente y los precios de los móviles nuevos no paran de subir, cada vez más personas optan por alternativas más sostenibles y económicas. Una de las opciones que más crecimiento ha experimentado en los &uacu …

Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” according to a spokesperson for the pharma.